.png)
Skin Substitute Billing 2026: What Changed and What It's Costing You
- Emily Carter
- Jul 22
- 5 min read
Do you bill for skin substitutes in a wound care practice? If so, 2026 already feels different. CMS changed the payment rules for these products on January 1.
Skin substitute billing in 2026 is no longer just about picking the right code. It's about a real cut in what you get paid. You may have already seen it show up on your remittance advice.
Here's the short version. CMS used to pay for each product at its own rate. Now it pays one flat rate for almost all of them. Most of the product cost gets folded into the procedure itself. That one change is already hurting margins across the whole specialty.
What actually changed in skin substitute billing for 2026
Before 2026, billing worked like this. You billed the skin substitute product on its own. You used a Q code, a special billing code tied to that exact product. The maker set the price. Medicare paid close to that price, plus a small extra amount. That model is gone.
Starting January 1, CMS pays one flat rate for most skin substitute products. That rate is $127.28 per square centimeter. It doesn't matter what brand you use. The rate stays the same whether your product costs $50 a square centimeter or $500.
CMS also changed how it classifies these products. Most skin substitutes used to be billed like drugs. Now CMS treats them as supplies that come bundled with the procedure. This is called "incident-to" billing, and it's a bigger deal than it sounds.
Most amniotic and placental grafts fall under a rule called 361 HCT/P. Those now get bundled into the procedure payment. Only products licensed as biologics under a different rule, called Section 351, still get billed on their own.
Why CMS made this change
This wasn't a small update. Medicare spending on skin substitutes grew fast. In 2019, it was about $250 million a year. By 2024, it topped $10 billion. One government report found spending jumped more than 640% in just two years.
Investigators found real problems. Some doctors outside of wound care were billing a lot of these claims. Some practices split claims to dodge payment limits. Some billing numbers didn't match what the makers said they sold.
CMS's answer was simple: flatten the rate. Remove the reason to pick the most expensive product. CMS expects total spending on skin substitutes to drop by almost 90%.
The three changes hitting your revenue hardest
1. The flat rate cuts into your margin on pricier products
Did your practice build volume around higher-cost products with strong separate pay? That extra money is mostly gone now. The procedure fee didn't go up to make up for it. If your product costs $300 per square centimeter, you now get paid $127.28 for it, unless you switch products or work out a better deal with your vendor.
2. You can't bill for wasted product anymore, in most cases
Before, you could use modifier JW to bill for product you threw away. You could use modifier JZ to say nothing was wasted. Those modifiers applied when skin substitutes were billed like drugs. Now that most of them are billed as supplies, JW and JZ don't apply anymore. If you throw away part of a package, you don't get paid for that part.
3. Prior authorization adds more work
A new program called WISeR started on January 1, 2026. It requires prior authorization for some Medicare claims before you can bill them. This applies in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. If your practice is in one of these states, expect more paperwork and more time before you can even apply the graft.
What to check in your practice this quarter
Here are a few things worth checking before your next batch of claims goes out.
Product-to-code match. Make sure every skin substitute you stock has the right code for its type, either 361 HCT/P or 351 BLA.
Your margin per product. Compare what you pay for each product to the new $127.28 rate.
Your notes. Keep writing down the product name, package size, how much you used, and how much you threw away. You can't bill for the waste anymore, but payers still want to see it documented.
Code pairing. Every claim needs two codes: a CPT code for the procedure (15271 to 15278, or C5271 to C5278 in a hospital setting) and a matching HCPCS code for the product itself.
Watch for updates. CMS updates these codes four times a year, in January, April, July, and October. Have someone on your team check this every quarter.
Where practices are already losing claims
Two mistakes keep showing up in denied claims. The first is billing debridement (codes 97597 or 11042) on top of the graft application. CMS already bundles debridement into the graft procedure. You can only bill it separately if you use a modifier like 59 or XU, and your notes truly back it up.
The second mistake is a mismatch. Maybe the wound size is wrong. Maybe the product type doesn't match the code you billed. Either one is enough to get your claim denied.
Getting your practice ready for what's next
These 2026 rules aren't a one-time fix. CMS updates skin substitute codes every quarter. The WISeR program could grow beyond six states. The practices that come out ahead are the ones that keep checking their billing, not the ones that fix it once and move on.
Is your billing team stretched too thin to keep up with all of this? Product codes, prior auth, and quarterly changes are exactly the kind of work 3 Axis RCM does for wound care practices every day. Expert Wound care billing services can show you where your billing stands under the new rules.
Frequently Asked Question
Can I still bill for wasted skin substitute material in 2026?
Only if the product is a biologic under Section 351. Most products fall under a different rule, called 361 HCT/P. These are now billed as supplies, not drugs. Medicare won't pay for any part you throw away. Keep writing it down in your notes anyway. Payers may still ask to see it.
What is the 2026 Medicare payment rate for skin substitutes?
CMS set one flat rate: $127.28 per square centimeter. This replaces the old rates, which used to be different for each product. It applies in doctor's offices and hospital outpatient settings. Products billed as biologics under Section 351 are the main exception.
Do I need prior authorization for skin substitute grafts now?
It depends on where your practice is. A program called WISeR now requires prior authorization for some Medicare claims. This applies in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. Outside those states, the normal rules still apply, but that could change.
Comments